Primary pediatric hyperhidrosis: A review of current treatment options

Pediatric Dermatology

Volumn 25, Issue 6, 2008, Pages 591-598

  Gelbard, Christina M ^a   Epstein, Hayley ^a   Hebert, Adelaide ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALUMINUM CHLORIDE; ALUMINUM SALT; ANTIPERSPIRANT AGENT; ASTRINGENT AGENT; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DILTIAZEM; FORMALDEHYDE; GLUTARALDEHYDE; GLYCOPYRRONIUM BROMIDE; HYDROCORTISONE; OXYBUTYNIN; PROPANTHELINE BROMIDE; SALICYLIC ACID; SYNAPTOBREVIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TANNIN;

AUTONOMIC DYSFUNCTION; BLURRED VISION; CHILDHOOD DISEASE; CLINICAL TRIAL; CONSTIPATION; CREAM; CURETTAGE; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; DRY SKIN; DRY THROAT; EARLY DIAGNOSIS; ERYTHEMA; HEMATOMA; HUMAN; HYPERHIDROSIS; INJECTION SITE PAIN; IONTOPHORESIS; LEG CRAMP; LIPOSUCTION; MINIMALLY INVASIVE SURGERY; MUSCLE ATROPHY; MUSCLE WEAKNESS; NONHUMAN; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SEDATION; SIDE EFFECT; SKIN ALLERGY; SKIN BURNING SENSATION; SKIN DISCOLORATION; SKIN IRRITATION; SKIN PRURITUS; SORE THROAT; SYMPATHECTOMY; TACHYCARDIA; TREATMENT OUTCOME; URINE RETENTION; WELLBEING; XEROSTOMIA;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AXILLA; BOTULINUM TOXINS; CHILD; CHOLINERGIC ANTAGONISTS; DERMATOLOGIC AGENTS; DERMATOLOGY; HUMANS; HYPERHIDROSIS; IONTOPHORESIS; PEDIATRICS; SWEAT GLANDS; SYMPATHECTOMY; THORACIC SURGICAL PROCEDURES;

EID: 57049157019     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00782.x     Document Type: Review

References (35)

1. Strutton DR, Kowalski JW, Glaser DA et al. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004 51 : 241 248.
2. Hamm H, Naumann MK, Kowalski JW et al. Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology 2006 212 : 343 353.
3. Lear W, Kessler E, Solish N et al. An epidemiological study of hyperhidrosis. Dermatol Surg 2007 33 : S69 S75.
4. Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. CMAJ 2005 172 : 69 75.
5. Cohen JL, Cohen G, Solish N et al. Diagnosis, impact, and management of focal hyperhidrosis: treatment review including botulinum toxin therapy. Facial Plast Surg Clin North Am 2007 15 : 17 30, v-vi.
6. Kreyden O, Böni R, Burg G. Hyperhidrosis and botulinum toxin in dermatology. Basel, Switzerland : Karger, 2001.
7. Shelley WB, Hurley HJ Jr. Studies on topical antiperspirant control of axillary hyperhidrosis. Acta Derm Venereol 1975 55 : 241 260.
8. Scholes KT, Crow KD, Ellis JP et al. Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate. Br Med J 1978 2 : 84 85.
9. Goh CL. Aluminum chloride hexahydrate versus palmar hyperhidrosis. Evaporimeter assessment. Int J Dermatol 1990 29 : 368 370.
10. Benohanian A, Dansereau A, Bolduc C et al. Localized hyperhidrosis treated with aluminum chloride in a salicylic acid gel base. Int J Dermatol 1998 37 : 701 703.
11. Connolly M, de Berker D. Management of primary hyperhidrosis: a summary of the different treatment modalities. Am J Clin Dermatol 2003 4 : 681 697.
12. Mijnhout GS, Kloosterman H, Simsek S et al. Oxybutynin: dry days for patients with hyperhidrosis. Neth J Med 2006 64 : 326 328.
13. Bajaj V, Langtry JA. Use of oral glycopyrronium bromide in hyperhidrosis. Br J Dermatol 2007 157 : 118 121.
14. Seukeran DC, Highet AS. The use of topical glycopyrrolate in the treatment of hyperhidrosis. Clin Exp Dermatol 1998 23 : 204 205.
15. Luh JY, Blackwell TA. Craniofacial hyperhidrosis successfully treated with topical glycopyrrolate. South Med J 2002 95 : 756 758.
16. Shaw JE, Abbott CA, Tindle K et al. A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Diabetologia 1997 40 : 299 301.
17. Ayan S, Topsakal K, Gokce G et al. Efficacy of combined anticholinergic treatment and behavioral modification as a first line treatment for nonneurogenic and nonanatomical voiding dysfunction in children: a randomized controlled trial. J Urol 2007 177 : 2325 2328 discussion 2328-2329.
18. Jongerius PH, van Tiel P, van Limbeek J et al. A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling. Arch Dis Child 2003 88 : 911 914.
19. Eisenach JH, Atkinson JL, Fealey RD. Hyperhidrosis: evolving therapies for a well-established phenomenon. Mayo Clin Proc 2005 80 : 657 666.
20. Duller P, Gentry WD. Use of biofeedback in treating chronic hyperhidrosis: a preliminary report. Br J Dermatol 1980 103 : 143 146.
21. Dolianitis C, Scarff CE, Kelly J et al. Iontophoresis with glycopyrrolate for the treatment of palmoplantar hyperhidrosis. Australas J Dermatol 2004 45 : 208 212.
22. Karakoc Y, Aydemir EH, Kalkan MT et al. Safe control of palmoplantar hyperhidrosis with direct electrical current. Int J Dermatol 2002 41 : 602 605.
23. Jeganathan R, Jordan S, Jones M et al. Bilateral thoracoscopic sympathectomy: results and long-term follow-up. Interact Cardiovasc Thorac Surg 2008 7 : 67 70.
24. Baumann LS, Halem ML. Botulinum toxin-B and the management of hyperhidrosis. Clin Dermatol 2004 22 : 60 65.
25. Glaser DA, Coleman WP, Loss R et al. 4-Year longitudinal data on the efficacy and safety of repeated botulinum toxin type A therapy for primary axillary hyperhidrosis. Presented at the 65th American Academy of Dermatology Conference 2007, Washington, DC, February 1-5, 2007.
26. Farrugia MK, Nicholls EA. Intradermal botulinum A toxin injection for axillary hyperhydrosis. J Pediatr Surg 2005 40 : 1668 1669.
27. Bhakta BB, Roussounnis SH. Treating childhood hyperhidrosis with botulinum toxin type A. Arch Dis Child 2002 86 : 68.
28. Vazquez-Lopez ME, Pego-Reigosa R. Palmar hyperhidrosis in a 13-year-old boy: treatment with botulinum toxin A. Clin Pediatr (Phila) 2005 44 : 549 551.
29. Ram R, Lowe NJ, Yamauchi PS. Current and emerging therapeutic modalities for hyperhidrosis, part 2: moderately invasive and invasive procedures. Cutis 2007 79 : 281 288.
30. Moya J, Ramos R, Morera R et al. Thoracic sympathicolysis for primary hyperhidrosis: a review of 918 procedures. Surg Endosc 2006 20 : 598 602.
31. Kestenholz PB, Weder W. Thoracic sympathectomy. Curr Probl Dermatol 2002 30 : 64 76.
32. Cohen Z, Shinar D, Levi I et al. Thoracoscopic upper thoracic sympathectomy for primary palmar hyperhidrosis in children and adolescents. J Pediatr Surg 1995 30 : 471 473.
33. Doolabh N, Horswell S, Williams M et al. Thoracoscopic sympathectomy for hyperhidrosis: indications and results. Ann Thorac Surg 2004 77 : 410 414 discussion 414.
34. Steiner Z, Cohen Z, Kleiner O et al. Do children tolerate thoracoscopic sympathectomy better than adults? Pediatr Surg Int 2007 24 : 343 347.
35. Cohen Z, Shinhar D, Mordechai J et al. Thoracoscopic upper thoracic sympathectomy for primary palmar hyperhidrosis. Harefuah 1996 131 : 303 305.